raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79087

Acquired partial lipodystrophy

Synonyms: Barraquer-Simons syndrome · Progressive cephalothoracic lipodystrophy

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial, Not applicable
Age of onset
Adolescent, Adult, Childhood
Status
active

A rare acquired lipodystrophy characterized by bilateral, symmetrical lipoatrophy of the upper body (face, neck, arms, thorax and sometimes upper abdomen) with sparing of the lower extremities and cephalothoracic progression. The disease may be associated with low serum levels of C3 and presence of C3-nephritic factor.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcquired partial lipodystrophyBarraquer-Simons syndrome · Progressive cephalothoracic lipodystrophy
frLipodystrophie partielle acquiseLipodystrophie céphalothoracique progressive · Syndrome de Barraquer-Simons
deLipodystrophie, partielle erworbeneBarraquer-Simons-Syndrom · Lipodystrophie, cephalo-thorakale progressive
esLipodistrofia parcial adquiridaLipodistrofia cefalotorácica progresiva · Síndrome de Barraquer-Simons
itLipodistrofia parziale acquisitaLipodistrofia cefalotoracica progressiva · Sindrome di Barraquer-Simons
nlVerworven partiële lipodystrofieProgressieve cefalothoracale lipodystrofie · Syndroom van Barraquer-Simons
ptLipodistrofia parcial adquiridaSíndrome de Barraquer-Simons
plNabyta częściowa lipodystrofiaPostępująca lipodystrofia głowy i klatki piersiowej · Zespół Barraquera i Simonsa
csParciální získaná lipodystrofieProgresivní cefalothorakální lipodystrofie · Barraquerův-Simonsův syndrom · Barraquer-Simonsův syndrom
ukНабута часткова ліподистрофіяСиндром Барракера-Саймонса · Прогресуюча цефалоторакальна ліподистрофія
zh获得性部分脂质营养不良进行性头胸脂肪营养不良
trEdinsel kısmi lipodistrofiBarraquer-Simons sendromu · İlerleyici sefalotorasik lipodistrofi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM608709Evalidated
ICD-10E88.1NTBTattributedvalidated
ICD-11EF01.0Especificvalidated
MONDO0012104Evalidated
MeSHC562448Evalidated
UMLSC0220989Evalidated
GARD10509Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
LMNB2Major susceptibility factor inAssessedHGNC:6638ENSG0000017661915034119p13.3lamin B216826530[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET
Point prevalence1-9 / 1 000 000—EuropeClass onlyValidatedEuropean Medicines Agency 2015[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100578Lipoatrophy
Frequent (79-30%)
HP:0002960Autoimmunity
HP:0005421Decreased circulating complement C3 concentration
HP:0000365Hearing impairment
HP:0001249Intellectual disability
HP:0100827Lymphocytosis
HP:0003198Myopathy
HP:0005328Progeroid facial appearance
HP:0001250Seizure
Occasional (29-5%)
HP:0002829Arthralgia
HP:0002230Generalized hirsutism
HP:0100820Glomerulopathy
HP:0001397Hepatic steatosis
HP:0002721Immunodeficiency
HP:0000855Insulin resistance
HP:0002907Microscopic hematuria
HP:0000093Proteinuria

Run the differential on the 1 obligate / very frequent terms

Annotation source: 24788242[PMID]_1246331[PMID]_18854390[PMID]_16826530[PMID]_22768673[PMID]

7

Sources for this card